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Abstract
Streptococcus pneumoniae, a natural constituent of nasopharyngeal flora in young children, is an important pathogen involved in var-
ious respiratory and invasive infections. Extensive antibiotic use has reduced morbidity and mortality associated with pneumococcal
infections but has also led to non-susceptibility of some serotypes. Implementation of pneumococcal conjugate vaccine (PCV) pro-
grammes results in reduced antibiotic usage and decreased antibiotic resistance. In California, the Kaiser Permanente study demon-
strated a 7.8% reduction in otitis media (OM) visits from 1995 to 1998 following seven-valent PCV (PCV7) administration while
decreasing antibiotic prescriptions by 5.4%. An Israeli study in day-care centres recorded a 17% reduction in antibiotic use in chil-
dren given nine-valent PCV. Similarly, a US study showed a 41.9% reduction in antibiotic prescriptions for acute OM (AOM) when
comparing pre-PCV7 to post-PCV7 utilization. In France, a comprehensive PCV7 vaccination programme showed a decrease in anti-
biotic treatment of AOM from 51.8% to 40.9% over 2 years. Carriage of penicillin-resistant pneumococci dropped from 15.4% to
6.7%. A similar reduction from 47.7% to 30.4% was seen in penicillin–non-susceptible pneumococci. Other studies demonstrated a
shift in serotype distribution. Carriage of vaccine-serotype pneumococci declined from 44.3% to 28.9% over a 2-year period, while
carriage of non-vaccine serotypes increased from 9.6% to 15.8%. During 6 years of follow-up surveillance, prevalence of serotype
19A increased from 8.6% to 12.6%, while highly penicillin-resistant strains decreased from 15.6% to 1.1%; no new serotype emer-
gence was observed. Implementation of PCV programmes should be accompanied by supportive education on restricting the use of
antibiotics.
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Introduction
Streptococcus pneumoniae is a natural constituent of normal
nasopharyngeal (NP) flora in young children. After NP colo-
nization, S. pneumoniae can spread to adjacent structures and
invade the bloodstream. In fact, S. pneumoniae is an impor-
tant pathogen involved in acute otitis media (AOM), pneu-
monia, empyema, bacteraemia, sinusitis, and many invasive
infections, including meningitis [1]. Although extensive use of
antibiotics has led to reduced morbidity and mortality associ-
ated with pneumococcal infections, non-susceptibility to anti-
biotics has become an unintended consequence. The use of
pneumococcal conjugate vaccines (PCVs) to reduce antibiotic
resistance should be considered.
Direct Impact of PCVs on Antibiotic Use
Two studies were conducted to evaluate the direct impact
of PCVs in reducing antibiotic prescriptions and respiratory
illnesses in children. The first study was the Kaiser Permanente
study in California [2], and the second was a study performed
in Israel among toddlers attending day-care centres [3].
The Kaiser Permanente study of 37 868 children con-
ducted during 1995–1998 demonstrated a 7.8% reduction in
visits because of otitis media [2]. The study also showed that
seven-valent PCV (PCV7) administration decreased antibiotic
prescriptions by 5.4% during the follow-up period, and
decreased second-line antibiotic prescriptions by 12.6%.
Overall, PCV7 prevented a total of 35 antibiotic prescrip-
tions per 100 vaccinated children [2].
The Israeli study was conducted among 264 children aged
12–35 months who were attending day-care centres [3]. Risk
reductions of 15%, 16% and 17% for upper respiratory tract
infections, lower respiratory tract problems, and otitis media,
respectively, were observed in children who were given
nine-valent PCV. A reduction in antibiotic use (17%) was also
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observed in children given nine-valent PCV [3]. A US study
comparing antibiotic prescriptions for AOM from 1997 (pre-
PCV7) to 2004 (post-PCV7) showed a 41.9% reduction in
antibiotic prescriptions following implementation of the PCV7
immunization programme [4].
NP Carriage Study in French Children
PCV7 was introduced in France in 2002 for use in children
aged <2 years. Within the same period, a national plan to
reduce antibiotic prescriptions was established. The aim of a
prospective study [5] was to document the rate of NP pneu-
mococcal carriage and to assess the impact of PCV7 on the
distribution and susceptibility of pneumococcal serotypes.
Concurrently, a campaign concerning appropriate antibiotic
use was launched.
The 3-year prospective study [5] involved 89 paediatri-
cians and was conducted in France. The study population
comprised children aged 6–24 months suffering from AOM.
Children treated with antibiotics 7 days prior to enrolment
were excluded from the study. Vaccination status, antibiotic
usage during the previous 3 months and microbiological test
results were collected. AOM was defined as tympanic opac-
ity associated with marked redness or bulging in combination
with fever (‡38.5C) and/or otalgia or irritability [5].
Reduction of antibiotic use
Analysis clearly showed a decline in antibiotic use following
initiation of the vaccination programme [5]. Prior to the rou-
tine use of PCV7, 51.8% of study patients had received anti-
biotics during the 3 months prior to enrolment. In the
following 2 years, a 21% reduction (p <0.001) in antibiotic
use (from 51.8% to 40.9%) was documented [5]. This reduc-
tion was comparable to the trend for reduction in antibiotic
use in France during the same period.
Penicillin resistance
The incidences of children carrying penicillin-susceptible
pneumococci (PSP), penicillin-non-susceptible pneumococci
(PNSP) and penicillin-resistant pneumococci (PRP) were ana-
lysed during the study. At the beginning of the study, 15.4%
of all children carried PRP. In the following 2 years, the num-
ber of children carrying PRP dropped to 6.7% (56.5% reduc-
tion, p <0.001). At the beginning of the study, 47.7% of the
children carried PNSP and, at the end of the study, 30.4% of
the children carried PNSP (36.3% reduction, p <0.001). At
the beginning of the study, 23.4% of the children carried PSP
and, at the end of the study, 28.9% of the children carried
PSP (23.5% increase, p = 0.07) [5].
Trends in serotype distribution
Several studies have demonstrated that implementation
of the PCV7 vaccination programme has significantly reduced
the carriage of vaccine-serotype pneumococci and increased
the carriage of non-vaccine serotypes [6–8]. Similar results
were obtained in the French NP carriage study [5]. The car-
riage of vaccine-serotype pneumococci declined from 44.3%
in 2002 to 28.9% in 2004 (p <0.001); the carriage of non-vac-
cine serotypes increased from 9.6% in 2002 to 15.8% in
2004 (p <0.001) [5].
Effect of immunization status and antibiotic use on NP
carriage
The effect of antibiotic use and vaccination on pneumococcal
carriage and penicillin susceptibility were evaluated across
four subgroups of the NP carriage study population [5]. The
population was segmented on the basis of vaccine status and
antibiotic use during the previous 3 months. The results
showed that non-vaccinated children who had received anti-
biotics within the previous 3 months had a nearly four-fold
greater risk (p <0.0001) of carrying PRP than vaccinated chil-
dren who had not received antibiotics (Table 1) [5].
NP carriage and serotype distribution before and after
implementation of PCV7 in France
A multivariate analysis showed that vaccination status, atten-
dance at a day-care centre, having a sibling and fever
‡38.5C were each associated with carriage of pneumococci
[5]. The analysis also showed that recent (previous 3 months)
antibiotic use and attendance at a day-care centre each
increased the risk of carriage of PNSP, and that recent anti-
biotic use alone increased the risk of carriage of PRP [5].
Results From a 6-year Surveillance Study
A recent study concerning NP pneumococcal carriage
provides data from 6 years of surveillance. During the
TABLE 1. Pneumococcal carriage and susceptibility
according to immunization status and antibiotic use [5]
No vaccine,
no ATB
(n = 718) (%)
No vaccine,
ATB
(n = 605) (%)
Vaccine,
no ATB
(n = 307) (%)
Vaccine,
ATB
(n = 266) (%)
PSP 32.1 20.2 28.0 19.2
PIP 28.1 34.2 26.1 26.7
PRP 10.3 16.2 4.2 8.6
No carriage 29.5 29.4 41.7 45.5
ATB, antibiotic treatment during the preceding 3 months; PIP, penicillin-interme-
diate; PRP, penicillin-resistant; PSP, penicillin-susceptible.
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6-year survey, the percentage of children who received
PCV7 increased from 7.8% in year 1 to 97.7% in year 6
(Cohen R, Levy C, Bonnet E, Lecuyer A, Fritzell B, Varon
E. 6th International Symposium on Pneumococci and Pneu-
mococcal Diseases, Reykjavik, Iceland, 8–12 June 2008.
Abstract P3-068). A significant reduction in pneumococcal
carriage was observed by year 3, which remained stable
through year 6. A continuing reduction in the prevalence
of vaccine serotypes was observed, which dropped from
44.6% in year 1 to 8.4% in year 6. The prevalence of
serotype 19A increased from 8.6% in year 1 to 12.6% in
year 6 (p = 0.003). Concomitantly, non-vaccine-serotype
carriage increased from 26.5% to 52.1%, but no emergence
of a new serotype was observed. Highly penicillin-resistant
strains decreased markedly, from 15.6% to 1.1%
(p < 0.001).
Conclusions
Pneumococcal NP carriage plays an important role in the
pathogenesis of infections and the spread of antibiotic-resis-
tant pneumococci. Studies conducted in the USA before and
after PCV7 licensing revealed a reduction in visits and anti-
biotic prescriptions because of otitis media. In France, from
2002 to 2004, the proportion of children who received anti-
biotics decreased. As a result, rates of highly penicillin-resis-
tant strains decreased from 15.4% to 6.7%. Serotype 19A
was the predominant serotype found in carriage in France.
This may have significant implications for the development of
pneumococcal vaccines.
Reducing unnecessary antibiotic prescriptions and
implementing PCV programmes are probably the two
most efficient strategies to lessen the burden of pneumo-
coccal disease. This implementation should be accompanied
by supportive education concerning restricted use of
antibiotics.
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